In last trading session, AEON Biopharma Inc (AMEX:AEON) saw 0.83 million shares changing hands with its beta currently measuring 0.47. Company’s recent per share price level of $0.50 trading at $0.01 or 1.40% at ring of the bell on the day assigns it a market valuation of $5.65M. That closing price of AEON’s stock is at a discount of -53756.0% from its 52-week high price of $269.28 and is indicating a premium of 24.0% from its 52-week low price of $0.38. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.33 million shares which gives us an average trading volume of 3.24 million if we extend that period to 3-months.
For AEON Biopharma Inc (AEON), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
AEON Biopharma Inc (AMEX:AEON) trade information
Upright in the green during last session for gaining 1.40%, in the last five days AEON remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $0.50 price level, adding 10.71% to its value on the day. AEON Biopharma Inc’s shares saw a change of -98.71% in year-to-date performance and have moved 5.62% in past 5-day. AEON Biopharma Inc (AMEX:AEON) showed a performance of 25.03% in past 30-days. Number of shares sold short was 68941.0 shares which calculate 0.17 days to cover the short interests.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
Insiders are in possession of 9.62% of company’s total shares while institution are holding 15.57 percent of that, with stock having share float percentage of 17.22%. Investors also watch the number of corporate investors in a company very closely, which is 15.57% institutions for AEON Biopharma Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 6.28 shares of worth $3138.0 or 0.06% of the total outstanding shares. The later fund manager was in possession of 5.76 shares on Dec 31, 2024 , making its stake of worth around $2881.0 in the company or a holder of 0.05% of company’s stock.
